We are live on
!
Find out more
CT
Cambridge Trust Portfolio holdings
AUM
$2.64B
Turnover
15.41%
1-Year Est. Return
28.73%
This Fund
S&P 500
This Quarter
Est. Return
+4.47%
1 Year Est. Return
+28.73%
3 Year Est. Return
+42.93%
5 Year Est. Return
+123.28%
10 Year Est. Return
+319.24%
AUM
$2.45B
AUM Growth
+$339M
(+16%)
Cap. Flow
+$259M
Cap. Flow
% of AUM
10.57%
Top 10 Holdings %
Top 10 Hldgs %
27.26%
Holding
275
New
45
Increased
102
Reduced
97
Closed
9
Avg Time Held
4.1
years
Top 10 Avg Time Held
2.7
years
Top 20 Avg Time Held
2.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$39.6M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$36.9M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$30.8M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$26.5M |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$25.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$23.2M |
| 2 |
Alibaba
BABA
|
+$21.9M |
| 3 |
Verizon
VZ
|
+$12.1M |
| 4 |
NextEra Energy
NEE
|
+$11.5M |
| 5 |
Meta Platforms (Facebook)
META
|
+$10.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.93% |
| 2 | Financials | 17.8% |
| 3 | Miscellaneous | 16.26% |
| 4 | Healthcare | 10.14% |
| 5 | Consumer Discretionary | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
151
iShares Russell 1000 Growth ETF
IWF
$124B
| $788K | 0.03% |
12,964
-356
| -3% | -$21.7K |
2015 Q2
23 quarters
|
|
152
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$11.2B
| $776K | 0.03% |
+24,777
| New | +$777K |
2021 Q1
0 quarters
|
|
153
Deere & Co
DE
$172B
| $723K | 0.03% |
1,932
+100
| +5% | +$32.8K |
2013 Q2
31 quarters
|
|
154
Corcept Therapeutics
CORT
$11.9B
| $718K | 0.03% |
30,200
| – | – |
2013 Q2
31 quarters
|
|
155
DuPont de Nemours
DD
$17.6B
| $716K | 0.03% |
7,379
-234
| -3% | -$22.4K |
2013 Q2
31 quarters
|
|
156
Wells Fargo
WFC
$250B
| $701K | 0.03% |
17,951
+86
| +0.5% | +$3.04K |
2013 Q2
31 quarters
|
|
157
Vanguard FTSE All-World ex-US ETF
VEU
$67B
| $665K | 0.03% |
+10,959
| New | +$667K |
2021 Q1
0 quarters
|
|
158
iShares Select Dividend ETF
DVY
$23.2B
| $656K | 0.03% |
5,753
-1,482
| -20% | -$157K |
2013 Q2
31 quarters
|
|
159
Colgate-Palmolive
CL
$74.4B
| $619K | 0.03% |
7,859
+3,258
| +71% | +$255K |
2019 Q2
7 quarters
|
|
160
Target
TGT
$69.8B
| $615K | 0.03% |
3,101
-73
| -2% | -$13.7K |
2019 Q2
7 quarters
|
|
161
Costco
COST
$438B
| $612K | 0.03% |
1,735
-51
| -3% | -$17.8K |
2014 Q3
26 quarters
|
|
162
FMC
FMC
$893M
| $584K | 0.02% |
5,283
-555
| -10% | -$61.5K |
2017 Q1
16 quarters
|
|
163
iShares MSCI EAFE ETF
EFA
$76.8B
| $579K | 0.02% |
7,643
-150
| -2% | -$11.3K |
2013 Q2
31 quarters
|
|
164
SPDR Gold Trust
GLD
$141B
| – | – |
0
| – | – |
2016 Q2
19 quarters
|
|
165
Pegasystems
PEGA
$5.67B
| $572K | 0.02% |
10,000
| – | – |
2017 Q1
16 quarters
|
|
166
ALPS Medical Breakthroughs ETF
SBIO
$175M
| $568K | 0.02% |
11,291
-5,840
| -34% | -$323K |
2017 Q1
16 quarters
|
|
167
Eaton
ETN
$152B
| $563K | 0.02% |
4,073
+97
| +2% | +$12.5K |
2019 Q1
8 quarters
|
|
168
Vanguard High Dividend Yield ETF
VYM
$81.5B
| $554K | 0.02% |
5,481
-700
| -11% | -$67.5K |
2013 Q2
31 quarters
|
|
169
TE Connectivity
TEL
$61.4B
| $536K | 0.02% |
+4,154
| New | +$534K |
2021 Q1
0 quarters
|
|
170
Comcast
CMCSA
$78B
| $530K | 0.02% |
9,806
+1,613
| +20% | +$85.2K |
2014 Q4
25 quarters
|
|
171
Littelfuse
LFUS
$9.74B
| $529K | 0.02% |
1,999
| – | – |
2019 Q1
8 quarters
|
|
172
Cognizant
CTSH
$29.5B
| $525K | 0.02% |
6,714
+24
| +0.4% | +$1.85K |
2013 Q2
31 quarters
|
|
173
iShares S&P 500 Growth ETF
IVW
$76.7B
| $520K | 0.02% |
7,992
-1,016
| -11% | -$65.7K |
2015 Q4
21 quarters
|
|
174
T-Mobile US
TMUS
$170B
| $513K | 0.02% |
4,094
+15
| +0.4% | +$1.89K |
2020 Q2
3 quarters
|
|
175
Broadridge
BR
$19.6B
| $509K | 0.02% |
+3,327
| New | +$491K |
2021 Q1
0 quarters
|
|
Similar funds
ZCM
CQS
SCM
AFIMH
DA
Cambridge Trust's Q1 2021 Portfolio in Review
As of Q1 2021, Cambridge Trust held 275 positions worth $2.45B, up 16% from $2.11B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Cambridge Trust deployed $259M of net new capital in Q1 2021, opening 45 new positions and adding to 102 existing holdings. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 264,440 shares worth $29.9M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 23% a quarter earlier, followed by Financials and Miscellaneous.
On the sell side, the largest reduction was Merck, an estimated $23.2M trimmed.
- Cambridge Trust's largest Q1 2021 buy was iShares 7-10 Year Treasury Bond ETF: 264,440 shares worth $29.9M.
- Cambridge Trust added most to iShares Core S&P 500 ETF in Q1 2021, an estimated $39.6M increase.
- Cambridge Trust's biggest Q1 2021 reduction was Merck, cutting an estimated $23.2M.
- Cambridge Trust fully exited Alibaba in Q1 2021, selling an estimated $21.9M.
- Cambridge Trust's ten largest holdings make up 27% of its $2.45B portfolio in Q1 2021.
- Cambridge Trust opened 45 new positions and closed 9 in Q1 2021.
- Cambridge Trust's portfolio value rose 16% quarter-over-quarter to $2.45B.
Based on Cambridge Trust's 13F filing for Q1 2021, filed 14 May 2021.